Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Remain Persuaded During Your Internet based Degree Program - 2Pick Your Favored kind of soup
- 3I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- 4Opening Potential: Self-awareness and Long lasting Learning
- 5Europe could get 42 more days of summer by the year 2100 due to climate change
- More parents refusing this shot that prevents serious bleeding at birth
- UNICEF: More than 100 children killed in Gaza since ceasefire
- Bombardier Global 8000 Enters Service
- 'Sex and the City' star Kim Cattrall marries longtime partner Russell Thomas in intimate London wedding
- Idris Elba is the king of the stress-watch
- The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs
- Every year, she thanks the trooper for the arrest that led to her sobriety
- Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- One dead, six wounded in various crime-related shootings in Israel over the weekend
